A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

Clinical trial NCT07765888 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07765888
Sponsor: Pfizer
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2026-08-14
Primary completion: 2028-02-29
Enrollment: 375

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.